| 國立臺灣大學 |
2011 |
Association of primary cutaneous amyloidosis with atopic dermatitis: a nationwide population-based study in Taiwan
|
Lee, D.D.; Huang, C.K.; Ko, P.C.; Chang, Y.T.; Sun, W.Z.; Oyang, Y.J. |
| 臺大學術典藏 |
2018-09-10T08:31:45Z |
Association of primary cutaneous amyloidosis with atopic dermatitis: A nationwide population-based study in Taiwan
|
Lee, D.D. Huang, C.K. Ko, P.C. Chang, Y.T. Sun, W.Z. Oyang, Y.J.Lee, D.D.;Huang, C.K.;Ko, P.C.;Chang, Y.T.;Sun, W.Z.;Oyang, Y.J.; Lee, D.D.; WEI-ZEN SUN; Huang, C.K.; Ko, P.C.; Chang, Y.T.; Sun, W.Z.; Oyang, Y.J. |
| 中國醫藥大學 |
2015-01 |
Association of Primary Immune Thrombocytopenia and Common Allergic Diseases Among Children
|
(Ming-Ru Chiang);魏長菁(Chang-Ching Wei);莫之欣;(Lin-Shien Fu);李采娟(Tsai-Chung Li);高嘉鴻(Chia-Hung Kao)* |
| 嘉南藥理大學 |
2022 |
Association of primary Sjogren's syndrome with incident heart failure: a secondary analysis of health claims data in Taiwan
|
Lin, Chun-Yu; Chen, Hung-An; Chang, Tsang-Wei; Hsu, Tsai-Ching; Hsu, Chung-Yuan; Su, Yu-Jih |
| 國立成功大學 |
2022 |
Association of primary Sjögren’s syndrome with incident heart failure: a secondary analysis of health claims data in Taiwan
|
Lin, C.-Y.;Chen, H.-A.;Chang, T.-W.;Hsu, T.-C.;Hsu, C.-Y.;Su, Y.-J. |
| 國立成功大學 |
2021-06-1 |
Association of Primary Treatment Modality for Advanced-Stage Oropharyngeal Squamous Cell Carcinoma With Survival Outcomes
|
Tsai;Mu-Hung;Cheng;Yung-Jen;Pao;Tzu-Hui;Hsueh;Wei-Ting;Chen;Helen, Helen H. W.;Wu;Yuan-Hua |
| 國家衛生研究院 |
2015-05 |
Association of prior antiplatelet agents with mortality in sepsis patients: A nationwide population-based cohort study
|
Tsai, MJ;Ou, SM;Shih, CJ;Chao, PW;Wang, LF;Shih, YN;Li, SY;Kuo, SC;Hsu, YT;Chen, YT |
| 臺北醫學大學 |
2015-10 |
Association of Processed Meat Intake with Hypertension Risk in Hemodialysis Patients: A Cross-Sectional Study
|
楊淑惠; Pei-Yu Wu, Shwu-Huey Yang, Te-Chih Wong, Tzen-Wen Chen, His-Hsien Chen, Tso-Hsiao Chen, Yu-Tong Chen |
| 臺大學術典藏 |
2020-02-06T06:49:51Z |
Association of progesterone production with serum anti-M?llerian hormone levels in assisted reproductive technology cycles with corifollitropin alfa
|
Lee T.-H;Tzeng S.-L;Lee C.-I;Chen H.-H;Huang C.-C;Shee-Uan Chen;Lee M.-S.; Lee T.-H; Tzeng S.-L; Lee C.-I; Chen H.-H; Huang C.-C; SHEE-UAN CHEN; Lee M.-S. |
| 中山醫學大學 |
2018-11-14 |
Association of progesterone production with serum anti-Müllerian hormone levels in assisted reproductive technology cycles with corifollitropin alfa
|
Tsung-Hsien Lee; Shu-Ling Tzeng; Chun-I Lee; Hsiu-Hui Chen; Chun-Chia Huang; Shee-Uan Chen; Maw-Sheng Lee |
| 國立成功大學 |
2023 |
Association of prognostic nutritional index with risk of contrast induced nephropathy: A meta-analysis
|
Chang, W.-T.;Sun, C.-K.;Wu, J.-Y.;Huang, P.-Y.;Liu, T.-H.;Chang, Y.-J.;Lin, Y.-T.;Kang, F.-C.;Hung, K.-C. |
| 嘉南藥理大學 |
2022 |
Association of Prognostic Nutritional Index with Severity and Mortality of Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
|
Hung, Kuo-Chuan; Ko, Ching-Chung; Wang, Li-Kai; Liu, Ping-Hsin; Chen, I-Wen; Huang, Yen-Ta; Sun, Cheuk-Kwan |
| 國立成功大學 |
2022-07 |
Association of Prognostic Nutritional Index with Severity and Mortality of Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
|
Hung;Kuo-Chuan;Ko;Ching-Chung;Wang;Li-Kai;Liu;Ping-Hsin;Chen;I-Wen;Huang;Yen-Ta;Sun;Cheuk-Kwan |
| 臺大學術典藏 |
2020-06-30T08:09:52Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Kang-Yi Su;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; KANG-YI SU; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020 |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2020-08-13T06:33:24Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yu C.-J.; Yang J.C.-H.; JIN-YUAN SHIH; Lin C.-C.; Lee J.-H.; Hsu W.-H.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu C.-L.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H. |
| 臺大學術典藏 |
2020-05-25T07:35:03Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yu C.-J.; Yang J.C.-H; Shih J.-Y; Yang C.-Y; Liao W.-Y; Ho C.-C; Chen K.-Y; Tsai T.-H; Hsu C.-L; Liu Y.-N; Su K.-Y; Chang Y.-L; Wu C.-T; Liao B.-C; Hsu C.-C; Hsu W.-H; Lee J.-H; Chia-Chi Lin |
| 臺大學術典藏 |
2020-12-24T03:18:46Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Chia-Lin Hsu;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; CHIA-LIN HSU; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-04-29T02:38:29Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Anonymous |
| 臺大學術典藏 |
2021-08-20T08:00:38Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; BIN-CHI LIAO; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-14T07:10:40Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-03-04T05:33:27Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:31Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-06-27T06:59:43Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-09-15T01:08:54Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Chia-Chi Lin; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
